Dacomitinib is a potent, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity.
Molecular Weight:
469.9
Purity:
99% (HPLC)
CAS Number:
[1110813-31-4]
Formula:
C24H25CIFN5O2
Target:
EGFR
* VAT and and shipping costs not included. Errors and price changes excepted